Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System

Increasingly broad patient groups are being treated with immune checkpoint inhibitors (ICIs) in clinical practice, but few studies have assessed their usage and outcomes in large, comprehensive real-world cohorts. We identified patients who received ICIs in the Veterans Affairs (VA) health care syst...

Descripción completa

Detalles Bibliográficos
Autores principales: La, Jennifer, Cheng, David, Brophy, Mary T., Do, Nhan V., Lee, Jerry S.H., Tuck, David, Fillmore, Nathanael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608595/
https://www.ncbi.nlm.nih.gov/pubmed/33074743
http://dx.doi.org/10.1200/CCI.20.00084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608595/
https://www.ncbi.nlm.nih.gov/pubmed/33074743
http://dx.doi.org/10.1200/CCI.20.00084

Ejemplares similares